Trading Update: Editas Medicine Inc (EDIT) Stock Endures 7.44% Monthly Volatility
In the past week, EDIT stock has gone down by -14.22%, with a monthly decline of -7.10% and a quarterly plunge of -28.78%. The volatility
In the past week, EDIT stock has gone down by -14.22%, with a monthly decline of -7.10% and a quarterly plunge of -28.78%. The volatility
In the past week, EDIT stock has gone down by -5.80%, with a monthly gain of 15.57% and a quarterly plunge of -18.08%. The volatility
The stock has a 36-month beta value of 2.05. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 0 as
, and the 36-month beta value for EDIT is at 1.98. The public float for EDIT is 81.05M, and currently, shorts hold a 15.06% of
and a 36-month beta value of 1.98. The public float for EDIT is 81.05M, and at present, short sellers hold a 15.06% of that float.
Editas Medicine Inc (NASDAQ: EDIT)’s stock price has plunge by 7.40relation to previous closing price of 14.87. Nevertheless, the company has seen a 2.64% surge
The stock price of Editas Medicine Inc (NASDAQ: EDIT) has jumped by 1.84 compared to previous close of 7.08. Zacks Investment Research reported 2024-02-06 that
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.